NCT01103037View on ClinicalTrials.gov

Efficacy, Safety and Pharmacokinetics of QAV680 Versus Placebo in Patients With Asthma

PHASE2TerminatedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2010

Conditions
Asthma
Interventions
DRUG

QAV680

QAV680 500 mg (5 x 100 mg capsules) four times per day

DRUG

QAV680 Placebo

Placebo to QAV680 5 capsules four times per day

Trial Locations (7)

27607

North Carolina Clinical Research, Raleigh

28207

American Health Research, Charlotte

90630

West Coast Clinical Trials, Cypress

Unknown

Novartis Investigative Site, Berlin

Novartis Investigative Site, Hamburg

Novartis Investigative Site, Wiesbaden

Novartis Investigative Site, Moscow

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY